Michael McAllister, MD
Ophthalmology · Wenatchee, WANPI 1619188042
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (50.2%), other and food and beverage — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by American Surgical Company, LLC at 50.2% of the total. Reporting peaked in 2024 at $7,188 and has fallen 99.7% since, to $22 in 2025. Among ophthalmology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $441.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- American Surgical Company, LLC$6K
- Carl Zeiss Meditec Digital Innovations LLC$6K
- Integra Lifesciences Corporation$16
- Lumibird Medical Inc.$6
What the payments were for
- Royalty or licence$5,97850%
- Food & beverage$220%
- Other$5,91450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| American Surgical Company, LLC | 24 | $5,978 |
| Carl Zeiss Meditec Digital Innovations LLC | 1 | $5,914 |
| Integra Lifesciences Corporation | 1 | $16 |
| Lumibird Medical Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERACITY SURGICAL$5,914
How this compares
$11,914 in reported general payments places this provider in the 90th percentile of 428 ophthalmology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 12 | $15,156 |
| Brimonidine Tartrate | 100 | $7,237 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 15 | $5,335 |
| Latanoprost | 305 | $4,249 |
| Timolol Maleate | 250 | $3,483 |
| Prednisolone Acetate | 70 | $2,352 |
| Dorzolamide Hcl | 67 | $2,229 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 67 | $1,857 |
| Travoprost | 30 | $1,856 |
| MoxifloxacinMoxifloxacin Hcl | 34 | $563 |
| ErythromycinErythromycin Base | 39 | $377 |
| Doxycycline Hyclate | 18 | $211 |
| Diclofenac Sodium | 14 | $166 |
| Ketorolac Tromethamine | 11 | $154 |
| Acyclovir | 26 | $143 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Wenatchee
- Anish KadakiaWenatchee$7K
- Valerie DawsonWenatchee$7K
- Austin RohlWenatchee$6K
- Ashton KalhornWenatchee$6K
- David SkaleWenatchee$6K
- Lynnelle NewellWenatchee$6K
- Joyce BerminghamWenatchee$6K
- Grace DunbarWenatchee$6K
- Laura PerimanSeattle$1.7M
- Sheldon CowenSeattle$560K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.